Researchers at the University of Edinburgh's Roslin Institute have used gene-editing techniques to produce pigs that are potentially resilient to African Swine Fever.

Bioengineer Gang Bao and team explore CRISPR-Cas9 alternatives

The aim of the research is to understand the genes human embryos need to develop successfully

For the first time, a litter of puppies was born by in vitro fertilization, thanks to work by Cornell researchers

New insect model may help eradicate disease that sickens millions annually

CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes

Dieter C. Gruenert, PhD, (bottom left) is a professor of otolaryngology—head and neck surgery at the University of California, San Francisco (UCSF) and pediatrics at the University of Vermont (UVM). He has a PhD in biophysics from the University of California at Berkeley and was a postdoctoral fellow in carcinogenesis at L’Institut Suisse de Recherche Expérimentale sur le Cancer in Lausanne. He was co- director of the Gene Therapy Core Center at UCSF, director of the Division of Human Molecular Genetics at  UVM, and head of the Stem Cell Research Program at California Pacific Medical Center. His research focuses on development of gene editing and cell-based therapies for inherited diseases and cancer. He has developed novel diagnostic and oligonucleotide-based therapeutic strategies to ameliorate disease pathology.

Researchers and other experts will explore the scientific, ethical, and policy issues associated with human gene-editing research at an international summit this fall.

Work reveals how a genome-editing tool works to correct errors in the genetic code.